{"id":236647,"date":"2025-02-10T13:23:58","date_gmt":"2025-02-10T11:23:58","guid":{"rendered":"https:\/\/eumedbridge.eu\/?post_type=news&#038;p=236647"},"modified":"2025-02-10T13:23:58","modified_gmt":"2025-02-10T11:23:58","slug":"la-berd-se-retire-dibnsina-pharma-en-egypte","status":"publish","type":"news","link":"https:\/\/www.eumedbridge.eu\/fr\/news\/la-berd-se-retire-dibnsina-pharma-en-egypte\/","title":{"rendered":"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte"},"content":{"rendered":"<p>La Banque europ\u00e9enne pour la reconstruction et le d\u00e9veloppement (BERD) a enti\u00e8rement c\u00e9d\u00e9 sa participation restante de 8,8 % dans Ibnsina Pharma via la Bourse \u00e9gyptienne (EGX). La Banque a acquis une participation de 20 % dans Ibnsina Pharma en 2015 gr\u00e2ce \u00e0 une combinaison de transactions primaires et secondaires pour financer le d\u00e9veloppement des entrep\u00f4ts, des centres de distribution et de la cha\u00eene d\u2019approvisionnement globale de la soci\u00e9t\u00e9. Depuis lors, la soci\u00e9t\u00e9 a connu une forte croissance, devenant le premier distributeur pharmaceutique sur le march\u00e9 \u00e9gyptien et se d\u00e9veloppant avec succ\u00e8s dans un certain nombre d\u2019op\u00e9rations non pharmaceutiques.<\/p>\n<p>&nbsp;<\/p>\n<p>Omar Abdel Gawad, le PDG d\u2019Ibnsina Pharma, a d\u00e9clar\u00e9 : \u00ab Notre partenariat avec la BERD a \u00e9t\u00e9 d\u2019une valeur inestimable pour notre croissance et notre expansion \u2013 un \u00e9l\u00e9ment cl\u00e9 de notre parcours pour devenir le premier acteur sur le march\u00e9 \u00e9gyptien. \u00bb Ibnsina Pharma est une soci\u00e9t\u00e9 par actions \u00e9gyptienne cr\u00e9\u00e9e en 2000, sp\u00e9cialis\u00e9e dans la distribution de produits pharmaceutiques. La soci\u00e9t\u00e9 est bas\u00e9e au Caire et exploite un r\u00e9seau national de points de distribution et d\u2019entrep\u00f4ts.<\/p>\n<p>&nbsp;<\/p>\n<p>La BERD a r\u00e9alis\u00e9 un certain nombre d\u2019investissements en fonds propres afin de promouvoir et de soutenir le secteur priv\u00e9 en \u00c9gypte, en investissant dans des soci\u00e9t\u00e9s telles qu\u2019Infinity (le plus grand d\u00e9veloppeur d\u2019\u00e9nergie renouvelable d\u2019Afrique), Hassan Allam Renewable Energy, Global Corp (une soci\u00e9t\u00e9 de leasing et d\u2019affacturage de premier plan) et Tamweely (une soci\u00e9t\u00e9 de microfinance de premier plan). La Banque a \u00e9galement investi avec succ\u00e8s dans des prestataires de soins de sant\u00e9 \u00e9gyptiens tels que Cleopatra Hospitals et Adwia\/KELIX bio, dont elle est d\u00e9sormais sortie.<\/p>\n","protected":false},"featured_media":236504,"parent":0,"template":"","news_category":[],"country":[1947],"special_action":[],"custom_tag":[2913],"class_list":["post-236647","news","type-news","status-publish","has-post-thumbnail","hentry","country-egypte","custom_tag-economie"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l&#039;UE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l&#039;UE\" \/>\n<meta property=\"og:description\" content=\"La Banque europ\u00e9enne pour la reconstruction et le d\u00e9veloppement (BERD) a enti\u00e8rement c\u00e9d\u00e9 sa participation restante de 8,8 % dans Ibnsina Pharma via la Bourse \u00e9gyptienne (EGX). La Banque a acquis une participation de 20 % dans Ibnsina Pharma en 2015 gr\u00e2ce \u00e0 une combinaison de transactions primaires et secondaires pour financer le d\u00e9veloppement des [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/\" \/>\n<meta property=\"og:site_name\" content=\"Voisins de l&#039;UE\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eumedbridge\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"354\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@eumedbridge\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/\",\"url\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/\",\"name\":\"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l'UE\",\"isPartOf\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg\",\"datePublished\":\"2025-02-10T11:23:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage\",\"url\":\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg\",\"contentUrl\":\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg\",\"width\":750,\"height\":354},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.eumedbridge.eu\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/www.eumedbridge.eu\/fr\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eumedbridge.eu\/#website\",\"url\":\"https:\/\/www.eumedbridge.eu\/\",\"name\":\"EU Medbridge\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eumedbridge.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.eumedbridge.eu\/#organization\",\"name\":\"EU Medbridge\",\"url\":\"https:\/\/www.eumedbridge.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.eumedbridge.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2021\/12\/Logo.png\",\"contentUrl\":\"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2021\/12\/Logo.png\",\"width\":325,\"height\":114,\"caption\":\"EU Medbridge\"},\"image\":{\"@id\":\"https:\/\/www.eumedbridge.eu\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/eumedbridge\/\",\"https:\/\/x.com\/eumedbridge\",\"https:\/\/www.linkedin.com\/company\/eumedbridge\",\"https:\/\/www.youtube.com\/@eumedbridge\",\"https:\/\/www.instagram.com\/eumedbridge\",\"https:\/\/www.flickr.com\/photos\/euneighbours-south\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l'UE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/","og_locale":"fr_FR","og_type":"article","og_title":"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l'UE","og_description":"La Banque europ\u00e9enne pour la reconstruction et le d\u00e9veloppement (BERD) a enti\u00e8rement c\u00e9d\u00e9 sa participation restante de 8,8 % dans Ibnsina Pharma via la Bourse \u00e9gyptienne (EGX). La Banque a acquis une participation de 20 % dans Ibnsina Pharma en 2015 gr\u00e2ce \u00e0 une combinaison de transactions primaires et secondaires pour financer le d\u00e9veloppement des [&hellip;]","og_url":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/","og_site_name":"Voisins de l'UE","article_publisher":"https:\/\/www.facebook.com\/eumedbridge\/","og_image":[{"width":750,"height":354,"url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@eumedbridge","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/","url":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/","name":"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte - Voisins de l'UE","isPartOf":{"@id":"https:\/\/www.eumedbridge.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage"},"image":{"@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg","datePublished":"2025-02-10T11:23:58+00:00","breadcrumb":{"@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#primaryimage","url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg","contentUrl":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2025\/02\/1395324809850.jpg","width":750,"height":354},{"@type":"BreadcrumbList","@id":"https:\/\/www.eumedbridge.eu\/news\/ebrd-exits-ibnsina-pharma-in-egypt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eumedbridge.eu\/fr\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/www.eumedbridge.eu\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"La BERD se retire d\u2019Ibnsina Pharma en \u00c9gypte"}]},{"@type":"WebSite","@id":"https:\/\/www.eumedbridge.eu\/#website","url":"https:\/\/www.eumedbridge.eu\/","name":"EU Medbridge","description":"","publisher":{"@id":"https:\/\/www.eumedbridge.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eumedbridge.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.eumedbridge.eu\/#organization","name":"EU Medbridge","url":"https:\/\/www.eumedbridge.eu\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.eumedbridge.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2021\/12\/Logo.png","contentUrl":"https:\/\/www.eumedbridge.eu\/wp-content\/uploads\/2021\/12\/Logo.png","width":325,"height":114,"caption":"EU Medbridge"},"image":{"@id":"https:\/\/www.eumedbridge.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eumedbridge\/","https:\/\/x.com\/eumedbridge","https:\/\/www.linkedin.com\/company\/eumedbridge","https:\/\/www.youtube.com\/@eumedbridge","https:\/\/www.instagram.com\/eumedbridge","https:\/\/www.flickr.com\/photos\/euneighbours-south\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/news\/236647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/media\/236504"}],"wp:attachment":[{"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/media?parent=236647"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/news_category?post=236647"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/country?post=236647"},{"taxonomy":"special_action","embeddable":true,"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/special_action?post=236647"},{"taxonomy":"custom_tag","embeddable":true,"href":"https:\/\/www.eumedbridge.eu\/fr\/wp-json\/wp\/v2\/custom_tag?post=236647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}